SCCA Clinical Trials at Confluence Health

Confluence Health

Below are some of the SCCA clinical trials now being offered for patients at Confluence Health. If you have any questions about these or other trials, please contact Confluence Health.

Bladder Cancer

Breast Cancer (Newly Diagnosed)

Breast Cancer (Recurrent/Metastatic)

Colon Cancer

Gynecologic Cancer (Recurrent/Metastatic)

  • Carboplatin + Paclitaxel w/wo Bevacizumab After Surgery (GOG 213)
    A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

Head/Neck Cancer

Prostate Cancer